Search
for

    Did you mean PPAR-gamma agonists?
    GlossaryPPAR-gamma agonists

    activate receptors to regulate glucose and lipid metabolism

    PPAR-gamma agonists, also known as Peroxisome Proliferator-Activated Receptor Gamma agonists, are a class of drugs that activate the PPAR-γ receptor, a type of nuclear receptor involved in regulating genes related to glucose and lipid metabolism. These agonists are commonly used in the treatment of conditions like type 2 diabetes because they help improve insulin sensitivity and reduce blood sugar levels.

    Related Terms

    Learn

    0 / 0 results
    — no results

    Research

    5 / 737 results

    Community Join

    5 / 8 results
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 4 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community The Worst Hair Loss Condition You (MAY) have: LPP

      in Research/Science  43 upvotes 3 months ago
      Lichen Planopilaris (LPP) is an autoimmune condition causing permanent hair loss and fibrosis, often misdiagnosed. Treatments include pioglitazone, topical corticosteroids, anti-inflammatory medication, and Jak inhibitors.

      community A concise, easy-to-understand post on Androgenic Alopecia theory and its practical applications

      in Research/Science  92 upvotes 2 years ago
      The mechanism of Androgenic Alopecia and practical applications of treatments like Minoxidil, Finasteride, RU58841, dermarolling, scalp massages, anti-fungals, progesterone, estrogen, PPAR-γ activators, reducing oxidative stress, and scalp exercises. It explains why DHT is important in AA and how other factors might be involved such as hypoxia, increased DKK-1 expression, morphological changes to the scalp, skull growth during childhood/puberty, and blood flow.